These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 12874969)

  • 41. When times get tough.
    Jong S
    Nat Biotechnol; 2009 Mar; 27(3):226-8. PubMed ID: 19274868
    [No Abstract]   [Full Text] [Related]  

  • 42. Five IP tips to spread your business wings.
    Cullem JG
    Nat Biotechnol; 2008 Nov; 26(11):1217-9. PubMed ID: 19009693
    [No Abstract]   [Full Text] [Related]  

  • 43. VC funding hits high in Q1.
    Lawrence S
    Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825
    [No Abstract]   [Full Text] [Related]  

  • 44. New biotech hubs may emerge as industry matures.
    Basu P
    Nat Biotechnol; 2003 Oct; 21(10):1123. PubMed ID: 14520385
    [No Abstract]   [Full Text] [Related]  

  • 45. Sumitomo buys Oxford finance.
    Bouchie A
    Nat Biotechnol; 2004 Apr; 22(4):480. PubMed ID: 15085808
    [No Abstract]   [Full Text] [Related]  

  • 46. Financing the Future II, Report 2. Strategies for effective capital structure management. Executive summary.
    Healthc Financ Manage; 2005 Aug; 59(8):36-8. PubMed ID: 16119121
    [No Abstract]   [Full Text] [Related]  

  • 47. Syndication--value in numbers.
    Sanborn KT
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE54-6. PubMed ID: 12089590
    [No Abstract]   [Full Text] [Related]  

  • 48. Life support for life science innovation?
    Nat Biotechnol; 2007 Feb; 25(2):144. PubMed ID: 17287731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assets for mastering media relations.
    Steinerman P
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE59-61. PubMed ID: 12874984
    [No Abstract]   [Full Text] [Related]  

  • 50. Giving your spinout the right spin.
    McElroy D
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE39-41. PubMed ID: 12874978
    [No Abstract]   [Full Text] [Related]  

  • 51. Biotech IPOs: handle with care.
    Jacobs T
    Nat Biotechnol; 2003 Dec; 21(12):1437. PubMed ID: 14647322
    [No Abstract]   [Full Text] [Related]  

  • 52. Snaring a venture capital investment.
    Lytton M
    Nat Biotechnol; 1998 May; 16 Suppl():54. PubMed ID: 9591272
    [No Abstract]   [Full Text] [Related]  

  • 53. Reinventing the biotech manager.
    Li J; Halal WE
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE61-3. PubMed ID: 12089592
    [No Abstract]   [Full Text] [Related]  

  • 54. Don't go public, go private.
    Helmus MN; Rao AK
    Nat Nanotechnol; 2007 Dec; 2(12):735-6. PubMed ID: 18654417
    [No Abstract]   [Full Text] [Related]  

  • 55. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 56. Memorandum. Subject: preliminary preparations for a major capital campaign.
    Barnard PC
    J Natl Assoc Hosp Dev; 1984; ():5-8. PubMed ID: 10310416
    [No Abstract]   [Full Text] [Related]  

  • 57. Accessing capital to your advantage.
    Margolin H
    Provider; 1986 Sep; 12(9):12, 14. PubMed ID: 10311695
    [No Abstract]   [Full Text] [Related]  

  • 58. Acquisition financing: no money down?
    Monroe SM
    Contemp Longterm Care; 1988 Apr; 11(4):92, 94. PubMed ID: 10286602
    [No Abstract]   [Full Text] [Related]  

  • 59. Stranger in a strange land?
    Dahiyat B
    Nat Biotechnol; 2012 Nov; 30(11):1030-2. PubMed ID: 23138291
    [No Abstract]   [Full Text] [Related]  

  • 60. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.